Cargando…

Assessment of novel technologies in healthcare - off-label use of drugs and the ethics of implementation and distribution of COVID-19 vaccines

Detalles Bibliográficos
Autores principales:	Avelino-Silva, Vivian Iida, de Barros, Mario Thadeu Leme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693880/ https://www.ncbi.nlm.nih.gov/pubmed/35019043 http://dx.doi.org/10.31744/einstein_journal/2021ED6840

Ejemplares similares

Ethical trade-offs in vaccine development and distribution—Response to Gurwitz
por: Rid, Annette, et al.
Publicado: (2021)

COVID-19 and off label use of drugs: an ethical viewpoint
por: Shojaei, Amirahmad, et al.
Publicado: (2020)

Ethical review of off-label drugs during the COVID-19 pandemic
por: Li, Qiu-Yu, et al.
Publicado: (2022)

The Ethics of Using Off-Label Medications to Treat COVID-19
por: Huffman, Alan
Publicado: (2022)

Pediatric Off-Label COVID-19 Vaccination: The Concerns of Healthcare Professionals in Pakistan
por: Shakeel, Sadia, et al.
Publicado: (2022)

Ethical and legal framework and regulation for off-label use: European perspective
por: Lenk, Christian, et al.
Publicado: (2014)

Ethical use of off-label disease-modifying therapies for multiple sclerosis
por: Laurson-Doube, Joanna, et al.
Publicado: (2021)

Off-Label Use of COVID-19 Vaccines from Ethical Issues to Medico-Legal Aspects: An Italian Perspective
por: Ferorelli, Davide, et al.
Publicado: (2021)

Campaign, counseling and compliance with influenza vaccine among older persons
por: Avelino-Silva, Vivian Iida, et al.
Publicado: (2011)

Off-label prescribing for allergic diseases in children
por: Silva, Diana, et al.
Publicado: (2014)

The ethics of COVID-19 vaccine distribution
por: Nichol, Ariadne A., et al.
Publicado: (2021)

Off-label drugs for obesity
por: Morgan, Andy, et al.
Publicado: (2022)

Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs
por: Overbeek, J.K., et al.
Publicado: (2023)

Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use—Patient Harms and Prescriber Responsibilities
por: Van Norman, Gail A.
Publicado: (2023)

A failure in solidarity: Ethical challenges in the development and implementation of new tuberculosis technologies
por: Komparic, Ana, et al.
Publicado: (2019)

To Be or Not to Be Vaccinated? The Ethical Aspects of Influenza Vaccination among Healthcare Workers
por: Van Hooste, Wim Leo Celina, et al.
Publicado: (2019)

The ethical challenges facing the widespread adoption of digital healthcare technology
por: Zarif, Azmaeen
Publicado: (2022)

Off-label drugs for weight management
por: Hendricks, Ed J
Publicado: (2017)

Factors associated with incomplete vaccination and negative antibody test results for measles, mumps, and hepatitis A among children followed in the MINA-BRAZIL cohort
por: Ferreira, Midiã Silva, et al.
Publicado: (2023)

When is off-label off-road?
por: de Vries, E G E, et al.
Publicado: (2019)

When is off-label off-road?
por: de Vries, E G E, et al.
Publicado: (2019)

Real-life occurrence of bacterial sexually transmitted infections among PrEP users: improving the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae with multisite screening
por: Moreira, Jorge Salomão, et al.
Publicado: (2021)

Fair allocation of scarce medical resources during COVID-19 pandemic: ethical considerations
por: Satomi, Erika, et al.
Publicado: (2020)

Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021)

Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics
por: Lenk, Christian, et al.
Publicado: (2009)

Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
por: WANG, Weilan, et al.
Publicado: (2013)

FRAMEWORK FOR SYSTEMATIC IDENTIFICATION OF ETHICAL ASPECTS OF HEALTHCARE TECHNOLOGIES: THE SBU APPROACH
por: Heintz, Emelie, et al.
Publicado: (2015)

The Need for Developing Technology-Enabled, Safe, and Ethical Workforce for Healthcare Delivery
por: Sarbadhikari, Suptendra N., et al.
Publicado: (2020)

Is Off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications
por: Zhang, Melvyn W., et al.
Publicado: (2016)

Automated Detection of Off-Label Drug Use
por: Jung, Kenneth, et al.
Publicado: (2014)

A tale of two drugs: Off and on-label
por: Narayanan, Raja, et al.
Publicado: (2017)

Implementing a mandatory COVID-19 vaccine: ethical challenges
por: Arora, A
Publicado: (2022)

An Ethical Framework for the Design, Development, Implementation, and Assessment of Drones Used in Public Healthcare
por: Cawthorne, Dylan, et al.
Publicado: (2020)

Implementing technology in healthcare: insights from physicians
por: Ruiz Morilla, Maria Dolors, et al.
Publicado: (2017)

Ethics in Design and Implementation of Technologies for Workplace Health Promotion: A Call for Discussion
por: Roossien, Charlotte Christina, et al.
Publicado: (2021)

YELLOW FEVER PREVENTION STRATEGIES AWARENESS AMONG HIV-INFECTED PATIENTS IN SÃO PAULO, BRAZIL
por: Avelino-Silva, Vivian Iida, et al.
Publicado: (2014)

Exploration and Ethical Analysis of Open-label Pediatric Vaccine Trials in a Pandemic
por: Wolfe, Ian D., et al.
Publicado: (2021)

AVALIAÇÃO DO IMPACTO DA COVID-19 NO NÚMERO DE TESTES REALIZADOS PARA DIAGNÓSTICO DE SÍFILIS E PORCENTAGEM DE EXAMES POSITIVOS
por: de Morais, Gabriel Junqueira, et al.
Publicado: (2022)

Utilisation and Off-Label Prescriptions of Respiratory Drugs in Children
por: Schmiedl, Sven, et al.
Publicado: (2014)

Off-label use of drugs: An evil or a necessity?
por: Gota, Vikram, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hqasecce64jvn9c6540knmarug